Relaxin analogs and derivatives methods and uses thereof
Patent 5811395 Issued on September 22, 1998. Estimated Expiration Date: 
September 22, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 22, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMolecular cloning and characterization of a further gene sequence coding for human relaxin Use of relaxin in cardiovascular therapy Human relaxin polypeptides Human relaxin formulation Use of relaxin in the treatment of bradycardia Patent #: 5478807 InventorsAssigneeApplicationNo. 483476 filed on 06/07/1995US Classes:514/12, 25 or more peptide repeating units in known peptide chain structure514/21, Produced by or extracted from animal tissue530/324, 25 or more amino acid residues in defined sequence530/399Hormones, e.g., prolactin, thymosin, growth factors, etc.ExaminersPrimary: Robinson, Douglas W.Assistant: Touzeau, P. Lynn Attorney, Agent or FirmInternational ClassesA61K 038/16A61K 038/17 C07K 007/10 AbstractThe present invention relates to a relaxin analogs and derivatives, and uses thereof. The present invention further relates to compositions comprising a relaxin analogs and derivatives, and relaxin wherein such composition exhibits an additive or synergistic effect.Other References
|
| ||||||||||||||
